Therapeutic positioning of asciminib in chronic myeloid leukemia patients previously treated with multiple tyrosine kinase inhibitors in Qatar.
Saved in:
| Title: | Therapeutic positioning of asciminib in chronic myeloid leukemia patients previously treated with multiple tyrosine kinase inhibitors in Qatar. |
|---|---|
| Authors: | Ghasoub R; Department of Pharmacy, National Center for Cancer Care and Research, Doha, Qatar., Hamad A; Department of Pharmacy, National Center for Cancer Care and Research, Doha, Qatar., El Akiki S; Diagnostic Genomic Division, Hamad Medical Corporation, Doha, Qatar., Fareed S; Department of BMT & Hematology, NCCCR, Doha, Qatar., Ellahie A; Department of BMT & Hematology, NCCCR, Doha, Qatar., Ismael O; Department of BMT & Hematology, NCCCR, Doha, Qatar., Yassin MA; Department of BMT & Hematology, NCCCR, Doha, Qatar. yassinmoha@gmail.com. |
| Source: | Discover oncology [Discov Oncol] 2025 Oct 23; Vol. 16 (1), pp. 1959. Date of Electronic Publication: 2025 Oct 23. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2730-6011 |
|---|---|
| DOI: | 10.1007/s12672-025-03759-7 |
